BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34582671)

  • 1. Survival Analysis of Cervical Cancer Patients: A Case Study of Bhutan.
    Tshewang U; Satiracoo P; Lenbury Y
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2987-2993. PubMed ID: 34582671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
    Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study.
    Li H; Pang Y; Cheng X
    J Gynecol Oncol; 2020 Jan; 31(1):e8. PubMed ID: 31788998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
    Mwaliko E; Itsura P; Keter A; De Bacquer D; Buziba N; Bastiaens H; Jackie A; Obala A; Naanyu V; Gichangi P; Temmerman M
    BMC Cancer; 2023 Nov; 23(1):1104. PubMed ID: 37957644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.
    Chai Y; Wang T; Wang J; Yang Y; Gao Y; Gao J; Gao S; Wang Y; Zhou X; Liu Z
    BMC Cancer; 2014 Feb; 14():63. PubMed ID: 24495453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 9. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
    Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia.
    Anfinan N; Sait K
    Ann Saudi Med; 2020; 40(1):25-35. PubMed ID: 32026705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study.
    Xie G; Wang R; Shang L; Qi C; Yang L; Huang L; Yang W; Chung MC
    BMC Cancer; 2020 Sep; 20(1):833. PubMed ID: 32873257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
    Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
    Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model.
    Matsuo K; Purushotham S; Jiang B; Mandelbaum RS; Takiuchi T; Liu Y; Roman LD
    Am J Obstet Gynecol; 2019 Apr; 220(4):381.e1-381.e14. PubMed ID: 30582927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer.
    Polterauer S; Grimm C; Seebacher V; Rahhal J; Tempfer C; Reinthaller A; Hefler L
    Int J Gynecol Cancer; 2010 Aug; 20(6):1052-7. PubMed ID: 20683416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
    Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Rate of Cervical Cancer in National Referral Hospital in 2012 - 2014.
    Nuranna L; Fahrudin A
    Acta Med Indones; 2019 Apr; 51(2):145-150. PubMed ID: 31383829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
    Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
    J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
    Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
    Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
    Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
    Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.